12 men shed light on hidden side effect of rectal cancer care
NCT ID NCT01843218
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 30 times
Summary
This study looked at erectile dysfunction in 12 men treated for early-stage rectal cancer. The goal was to objectively measure sexual side effects after surgery using a special device called RIGISCAN® PLUS. The study did not test a new treatment, but aimed to better understand how common and severe these issues are.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER STAGE I are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institut Bergonié
Bordeaux, Aquitaine, 33000, France
Conditions
Explore the condition pages connected to this study.